Ameriprise
PRTK

Ameriprise’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Ameriprise’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,800
Closed -$80K – 3912
2020
Q4 		$80K Buy
+12,800
New +$75.3K ﹤0.01% 3703
2020
Q3 		– Sell
-27,682
Closed -$144K – 3808
2020
Q2 		$144K Sell
27,682
-22,433
-45% -$99.6K ﹤0.01% 3540
2020
Q1 		$158K Hold
50,115
– – ﹤0.01% 3474
2019
Q4 		$202K Sell
50,115
-350
-0.7% -$1.21K ﹤0.01% 3576
2019
Q3 		$218K Buy
50,465
+715
+1% +$2.86K ﹤0.01% 3529
2019
Q2 		$198K Sell
49,750
-1,300
-3% -$6.18K ﹤0.01% 3590
2019
Q1 		$273K Buy
51,050
+1,140
+2% +$7.36K ﹤0.01% 3472
2018
Q4 		$256K Sell
49,910
-35,952
-42% -$273K ﹤0.01% 3393
2018
Q3 		$833K Buy
85,862
+29,400
+52% +$297K ﹤0.01% 3142
2018
Q2 		$576K Buy
56,462
+5,855
+12% +$66.3K ﹤0.01% 3204
2018
Q1 		$658K Buy
50,607
+12,229
+32% +$182K ﹤0.01% 3127
2017
Q4 		$687K Buy
38,378
+17,247
+82% +$360K ﹤0.01% 3120
2017
Q3 		$531K Sell
21,131
-27,170
-56% -$632K ﹤0.01% 3199
2017
Q2 		$1.16M Buy
+48,301
New +$1.07M ﹤0.01% 2875
2013
Q3 		– Sell
-13
Closed – – 5693
2013
Q2 		$0 Buy
+13
New +$557 ﹤0.01% 5588

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise's PRTK Position: Q1 2021 in Review

Ameriprise sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q1 2021, closing a stake of 12,800 shares — an estimated $80K sold.

Ameriprise first reported a position in PRTK in Q2 2013 and held it in 15 quarters. The position peaked at $1.16M in Q2 2017. 107 funds tracked by Wall St. Rank hold PRTK as of Q1 2021.

  • Ameriprise reported no remaining Paratek Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Ameriprise sold 12,800 Paratek Pharmaceuticals, Inc. shares in Q1 2021, an estimated $80K.
  • Ameriprise first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 15 quarters.
  • Ameriprise's Paratek Pharmaceuticals, Inc. position peaked at $1.16M in Q2 2017.
  • 107 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q1 2021.

Based on Ameriprise's 13F filing for Q1 2021, filed 17 May 2021.